Browse > Article

Modified Adenovirus Mediated Gene Transfer to Neuronal Precursor Cells  

Joung, In-Sil (Department of Biology, Hanseo University)
Publication Information
Korean Journal of Microbiology / v.42, no.1, 2006 , pp. 73-76 More about this Journal
Abstract
Neuronal precursor cells may provide for cell replacement or gene delivery vehicles in neurodegenerative disease therapy. One impediment to treating neuronal diseases is finding ways to introduce genes into neurons effectively. It is shown here that fiber-modified adenovirus vector delivered gene to neuronal precursor as well as differentiated neuronal cells more efficiently than first-generation adenoviral vector. Moreover, fiber-modified adenoviral vector transduced precursor cells retained the potential for differentiation into neurons and glia in vitro. These results show the potential of modified adenoviral vector in the improved gene delivery to neurons in direct gene therapy protocols. In addition it holds promise for the use of genetically manipulated stem cells for the therapy of neuronal diseases.
Keywords
adenovirus; differentiation; neuronal precursor cells; stem cell therapy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Silani, V. and M. Corbo. 2004. Cell-replacement therapy with stem cells in neurodegenerative diseases. Curr. Neurovasc. Res. 1, 283- 289   DOI
2 Benihoud, K., P. Yeh, and M. Perricaudet. 1999. Adenovirus vectors for gene delivery. Curr. Opin. Biotech. 10, 440-447   DOI   ScienceOn
3 Joung, I., H.J. Kim, and Y.K. Kwon. 2005. p62 modulates Akt activity via association with PKCξ in neuronal survival and differentiation. Biochem. Biophy. Res. Commun. 334, 654-660   DOI   ScienceOn
4 Breakefield X.O. 1993. Gene delivery into the brain using virus vector. Nature genetics 3, 187-189   DOI   ScienceOn
5 Dubois-Dalcq, M., C. Ffrench-Constant, and R.J. Franklin. 2005. Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48, 9-12   DOI   ScienceOn
6 Thomas, C.E., D. Birkett, I. Anozie, M.G. Castro, and P.R. Lowenstein. 2001. Acute direct adenoviral cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector- mediated transgene expression in the brain. Molecular Therapy 3, 36-46   DOI   ScienceOn
7 Wickham, T.J. 2000. Targeting adenovirus. Gene Ther. 7, 110-114   DOI
8 Li, H., H. Sun, and Z.M. Quin. 2002. The role of transferrin-transferrin- receptor system in drug delivery and targeting. Trends Phar.Sci. 23, 206-209   DOI   ScienceOn
9 Heistad, D.D., and F.M. Faraci. 1997. Gene therapy for cerebral vascular disease. Stroke 27, 534-539
10 Joung, I., G. Harber, K.M. Gerecke, S.L. Carroll. J.F. Collawn, and J.A. Engler. 2005. Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector. Biochem. Biophy. Res.Commun. 328, 1182-1187   DOI   ScienceOn
11 Lindvall, O., and Z. Kokaia. 2005. Stem cell therapy for human brain disorders. Kidney Int. 68, 1937-1939   DOI   ScienceOn
12 Joung, I., H.S. Kim, J.S. Hong, H. Kwon, and Y.K. Kwon. 2000. Effective gene transfer into regenerating sciatic nerves by adenoviral vectors: Potentials for gene therapy of peripheral nerve injury. Mol. Cells 10, 540-545   DOI   ScienceOn
13 Renfranz, P., M. Cunningham, and R.D. MaCkay. 1991. Region specific differentiation of hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66, 713- 729   DOI   ScienceOn
14 Vats, A., R.C. Bielby, N.S. Tolley, R. Nerem, and J.M. Polak. 2005. Stem cells. Lancet 366, 592-602   DOI   ScienceOn
15 Johansson, C.B., S. Momma, D.L. Clarke, M. Risling, U. Lendahl, and J. Frisen. 1999. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96, 25-34   DOI   ScienceOn